August 12, 2024 Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 08, 2024 Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
July 28, 2024 Ariceum Therapeutics Commences Phase 1 Clinical Trial in Patients with Recurrent Glioblastoma
July 22, 2024 First patient enters Oncopeptides study aiming to gain real-world insights from Pepaxti in Germany